BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22893223)

  • 1. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
    Razazi K; Derde LP; Verachten M; Legrand P; Lesprit P; Brun-Buisson C
    Intensive Care Med; 2012 Nov; 38(11):1769-78. PubMed ID: 22893223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
    Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
    Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
    Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
    Kallel H; Houcke S; Resiere D; Court T; Roncin C; Raad M; Nkontcho F; Demar M; Pujo J; Hommel D; Djossou F
    Am J Trop Med Hyg; 2022 Jan; 106(2):525-531. PubMed ID: 35008044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.
    Razazi K; Rosman J; Phan AD; Carteaux G; Decousser JW; Woerther PL; de Prost N; Brun-Buisson C; Mekontso Dessap A
    J Infect; 2020 May; 80(5):504-510. PubMed ID: 32142931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
    Kim J; Lee JY; Kim SI; Song W; Kim JS; Jung S; Yu JK; Park KG; Park YJ
    Ann Lab Med; 2014 Jan; 34(1):20-5. PubMed ID: 24422191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
    Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
    J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
    Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
    J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
    Prevel R; Boyer A; M'Zali F; Lasheras A; Zahar JR; Rogues AM; Gruson D
    Crit Care; 2019 May; 23(1):170. PubMed ID: 31088542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Boonsawang P; Treebupachatsakul P; Walsh TR; Niumsup PR
    Microb Drug Resist; 2019 Oct; 25(8):1182-1190. PubMed ID: 31140920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Razazi K; Mekontso Dessap A; Carteaux G; Jansen C; Decousser JW; de Prost N; Brun-Buisson C
    Ann Intensive Care; 2017 Dec; 7(1):61. PubMed ID: 28608133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum beta-lactamase producing
    Prevel R; Boyer A; M'Zali F; Cockenpot T; Lasheras A; Dubois V; Gruson D
    Antimicrob Resist Infect Control; 2019; 8():112. PubMed ID: 31333839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
    Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.
    Azim A; Dwivedi M; Rao PB; Baronia AK; Singh RK; Prasad KN; Poddar B; Mishra A; Gurjar M; Dhole TN
    J Med Microbiol; 2010 Aug; 59(Pt 8):955-960. PubMed ID: 20413621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France.
    Grall-Zahar I; Rucly S; Billard-Pomares T; Gasnier-Besnardeau K; Al Mouft O; Zahar JR; Zirnhelt I
    Infect Dis Now; 2022 Oct; 52(7):403-407. PubMed ID: 35914711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
    Timsit JF; Pilmis B; Zahar JR
    Semin Respir Crit Care Med; 2017 Jun; 38(3):287-300. PubMed ID: 28578553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
    Vodovar D; Marcadé G; Rousseau H; Raskine L; Vicaut E; Deye N; Baud FJ; Mégarbane B
    Infection; 2014 Aug; 42(4):743-8. PubMed ID: 24728816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) rectal carriage in cancer patients admitted to the intensive care unit.
    Issa N; Coppry M; Ripoche E; Guisset O; Mourissoux G; Bessede E; Camou F
    Infect Dis Now; 2022 Mar; 52(2):104-106. PubMed ID: 34922035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.